FY2024 EPS Estimates for Integer Raised by Zacks Research

Integer Holdings Co. (NYSE:ITGR) – Stock analysts at Zacks Research upped their FY2024 earnings per share (EPS) estimates for Integer in a note issued to investors on Thursday, November 14th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings per share of $5.32 for the year, up from their previous forecast of $5.28. The consensus estimate for Integer’s current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Integer’s Q4 2024 earnings at $1.45 EPS, Q1 2025 earnings at $1.30 EPS, Q2 2025 earnings at $1.45 EPS, Q4 2025 earnings at $1.69 EPS, FY2025 earnings at $5.99 EPS, Q1 2026 earnings at $1.63 EPS and Q2 2026 earnings at $1.57 EPS.

Several other equities research analysts have also weighed in on the company. KeyCorp boosted their target price on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a report on Tuesday, October 15th. Citigroup boosted their target price on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. Bank of America boosted their target price on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. Truist Financial cut their price target on Integer from $150.00 to $147.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Benchmark upped their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $139.75.

Integer Trading Down 0.7 %

NYSE:ITGR opened at $133.53 on Monday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. Integer has a 1-year low of $84.75 and a 1-year high of $140.91. The firm has a market capitalization of $4.48 billion, a price-to-earnings ratio of 41.21, a price-to-earnings-growth ratio of 1.91 and a beta of 1.09. The stock has a fifty day simple moving average of $129.41 and a 200 day simple moving average of $122.93.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. During the same quarter last year, the company posted $1.27 EPS. Integer’s revenue for the quarter was up 8.7% on a year-over-year basis.

Institutional Trading of Integer

Large investors have recently made changes to their positions in the business. Contravisory Investment Management Inc. lifted its stake in shares of Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 80 shares during the period. HighTower Advisors LLC lifted its stake in shares of Integer by 0.8% during the third quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider’s stock valued at $1,579,000 after acquiring an additional 90 shares during the period. Xponance Inc. lifted its stake in shares of Integer by 4.9% during the second quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock valued at $245,000 after acquiring an additional 99 shares during the period. Azzad Asset Management Inc. ADV lifted its stake in Integer by 0.9% in the third quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock valued at $1,504,000 after buying an additional 107 shares during the period. Finally, GAMMA Investing LLC lifted its stake in Integer by 60.9% in the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after buying an additional 142 shares during the period. Institutional investors own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.